How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available

Nir Eyal; Marc Lipsitch

doi:10.1093/cid/ciab182

How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available

Clin Infect Dis. 2021 Dec 16;73(12):2332-2334. doi: 10.1093/cid/ciab182.

Authors

Nir Eyal^{1

2}, Marc Lipsitch³

Affiliations

¹ Center for Population-Level Bioethics and Department of Philosophy, Rutgers University, New Brunswick, New Jersey, USA.
² Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, New Jersey, USA.
³ Center for Communicable Disease Dynamics, Department of Epidemiology, and Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.

Abstract

Although vaccines against severe acute respiratory syndrome coronavirus 2 have now been found safe and efficacious, there remains an urgent global health need to test both these vaccines and additional vaccines against the same virus. Under variable conditions, either standard or unusual designs would for both familiar and often-missed reasons make continued testing possible and ethical.

Keywords: COVID-19 vaccine; ethics; randomized controlled trials as topic.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Humans
Morals
SARS-CoV-2
Vaccines*

Substances

Vaccines

Abstract

Publication types

MeSH terms

Substances

Grants and funding